G McCullagh, M Main, F Muntoni… - 9th EPNS …, 2011 - epns2011.com Age at salbutamol treatment was 4.8 - 18.4y (median 9.75y), therapy duration 1 month to 8y (median 11m). Reported benefits included increased stamina, prolonged walking distance and reduced falls. Analysis of objective response measures, myometry, timed tests and ... Cached
FC Sciurba, N Siafakas, T Troosters… - American Journal of …, 2011 - Am Thoracic Soc University of Pittsburgh, Pittsburgh, PA, Medical School, University of Crete, Heraklion, Greece, UZ Gasthuisberg, Leuven, Belgium, 1 2 ... Pfizer Inc., New London, CT, Pfizer Inc., New York, NY 5 ... Tiotropium has been shown to produce sustained improvement in ... All 2 versions
JO Onyechi, C Marriott… - Journal of Pharmaceutical and …, 2011 - ajol.info Inhalation of drugs offers the opportunity to treat diseases of the respiratory tract. The use of dry powder inhalers is preferred to metered dose inhalers and nebulizers in this mode of drug delivery delivery. A multi-dose dry powder inhaler device, KCHALER TM device, which delivers ... Cached
JJ Salomon, K Hosoya… - American Journal of …, 2011 - Am Thoracic Soc Trinity College Dublin, Dublin, Ireland, University of Toyama, Toyama, Japan 1 2 ... Rationale. Formoterol and salbutamol (albuterol), two β -receptor agonists used in the treatment of COPD and asthma, carry a cationic ... C]-tetraethylammonium (TEA, 10 µM), [ H]- ... All 3 versions
MH Nielsen… - Medicine & Science in Sports & Exercise, 2011 - journals.lww.com PURPOSE: The prevalence of asthma is higher among elite athletes than in the general population. This has resulted in frequent use of anti-asthmatic medication such as beta2-agonist among asthmatic athletes. However, beta2-agonists are on the prohibited list of WADA. ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
